Clinical trial
Improved Glycemic Control in Diabetic Patients in Hemodialysis Using Continuous Glucose Monitoring (CGM)
NCT05678712 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improved Glycemic Control in Diabetic Patients in Hemodialysis Using Continuous Glucose Monitoring (CGM)
- Lead sponsor
- Aalborg University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 9, 2022
- Completion date
- December 18, 2023
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodialysis, type1diabetes, type2diabetes